Clinical Trial Update: A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating R1507 in combination with letrozole for postmenopausal women with advanced breast cancer has been terminated, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• R1507

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-11-13